Always amazes me how volume doubles just before the market closes--HMMMM. Sat at around 7,500 shares all morning!

Just remember the SP is intentionally being driven down on every PR, Q, and CC on purpose. When the Q gets better and better and the profits go up this will stop as it will be hard to hide anymore and will draw the attention of the SEC

Namtae- We agree on something! I do not mind the hedge funds accumulating ELTP/ I just accumulate along with them. I take advantage of all their hard work. I know it will end soon. I know the revenue is going up for sure but to a Newbie this is all very confusing! Hedge funds profit going down and they profit going up. Hedge funds do not pick bad stocks to play like this.

They are not retail investors but usually hedge funds, dark pools, overseas hedge funds. Their transactions are not all recorded which is why the volume counts on shorting is never correct.

Every time good news comes out they short the hell out of it to keep the SP from going up so they can keep accumulating cheap shares. However, when it gets real obvious that the SP does not match the revenue and they risk an SEC investigation they will stop and let it ride up. We are not far from that point now. It is just a matter of accumulating cheap shares for as long as they can by holding the SP down as long as they can get away with it.

As long as selling the shares to hold the price down results in buying back more shares at the end of the day when they paint the tape, this will continue. The object is to accumulate shares as cheaply as can be done. However, we are coming to the tipping point soon at which point it will no longer be worth the effort and they will let it run and profit again on the way up.

Potential is hype if not backed by research and patents and FDA approval. Hype is potential when backed by research, patents, and FDA approval which is the case for ELTP.

I agree with N2K! Can’t wait for the next Q! Soon the nonsense will end!

Yes they will if it costs less to make it.

Snup- Nice post. Yes, we must keep moving forward. Fortunately, as N2k noted, Nasrat is diversifying with many other drugs to keep generating more income to support further research efforts while we wait for SequestOx. Eventually, when the time is right we will move off the OTC and onto the NASDAQ.

JJ- Nice post. Thanks.

BP is truly threatened by ELTP being able to manufacture drugs at 10% of the cost. This is a massive paradigm shift in the pharma world to be sure. It could bring down many BP companies. There would be no contest. Nasrat is smart by bringing in the Chinese. He is saying play ball or I will go to the Chinese which will also ruin BP but many Americans will lose their jobs. Hopefully the FDA will see the error of their ways. BP will ultimately deal with ELTP and it will be costly either by threatening the existence of BP companies or an expensive buyout.

EPIC could be being paid off to delay ELTP drugs getting to market. ELT P needs to get out of EPIC and get their drugs on the market ASAP. No excuse for delaying Norco and Percocet or any drug approved by the FDA. Hopefully Sungen and Glenmark can get things going.

YJ4Life- We have both been here a long time. GLTY.

I agree. I think waiting out the Epic contract has delayed our progress. I am sure their were some legal reasons for delaying any news as it related to Epic. Epic did nothing for us. Hopefully soon or at the CC their will be good news. The ending of the Epic contract probably explains why Nasrat was slow to get Norco and Percocet to market. Glenmark has to be better!!!!

As has been discussed in the past many times there are pathways forward:1. Wait for the FDA and not antagonize the FDA 2. Begin advertising advantages of SequestOx 3. Consider production in Canada and Europe 4. Push forward with China deals 5. Take the political route after the Democrats win the house. The good news is the FDA gave us Narco and Percocet. Whatever pathway forward patience is needed.

n2k- Great post !I am also excited about the new process coming which will reduce manufacturing costs by 90%. The FDA will hopefully speed up the process once they realize drugs can be manufactured for far less. Big P will hate this. Our Sequestox is far superior and now we can outmanufacture them as well, decreasing the costs for drugs, in addition to just being generic. Big bucks on a buyout coming sometime at the end of 2019.

IB- Nasrat is alrerady a rich man. There is something in his past with BigP that says-"I'll show them". Something happened back then and Nasrat was not happy about it. Nasrat is not going to sell out for a low SP at this point after all this time. No way. He wants to be a billionaire and this is his ticket to "show them". I am hoping over $5.00 SP.

jour-trader-I agree. Because Nasrat is the majority stock holder he could increase the shares anytime he wants. However, I think it would just be made part of the deal in the buyout. Otherwise, this acts kind of like a poison pill in a sense that there could not be a take over immediately but also because Nasrat is the majority shareholder. So I think it is a non issue but in the end would need to be made "whole" at some point.

With Nasrat at the helm we will not end up like Pain Therapeutics.

Well, For sure if Remoxy passes then Sequestox is a shoe-in favorite to get approved. If Remoxy fails again then also good for ELTP because Sequestox is so much better. Hopefully, then FDA will look at Sequestox soon. FDA has to do something about abuse.

N2k Nice post. ELTP will not be involved in lawsuits against big pharm as we have come late to the party. As you pointed out- we will be charging less than big pharma. What a win-win situation!

Gman- No worries. Manipulation. Don't you think that it is very very strange that out of the blue 1.2 million shares are in play on a Friday afternoon when no one is looking. I am not a believer in OTC statistics and volume figures. Statistics good on NYSE. So where did all those shares disappear to?Those shares were buys to cover shorts in the end. If there were sells but no buys then that is a problem. Shaking the tree once more. Next week should be very interesting.

N2K-Excellent post. We will also have a pricing advantage.

So why do you think that dark money on dark exchanges from overseas hedge funds are going to give a courtesy call to the OTC and tell them they bought 100,000 shares and that they should change their end of the day volume count? Varoius estimates over the years show the OTC volume count to be between 60-75% accurate.

I agree with Gman24. Nasrat is not required to talk about every dotted "i" and crossed "t". Nasrat has always informed us of major roadblocks but those CDL letters have come with recommendations towards the goal of getting Sequestox approved.

Show me exactly where the FDA is not and never will ever approve Sequestox. A CDL letter is not a total final rejection of Sequestox. CDL letters come with recommendations to get to approval. Same thing happens with patents all the time. Companies all the time get "final rejection" on patents but requiring minor tweaking or modification of wording then the patent is granted.

ELTP not listed among firms selected by article. HOwever, this would be a great opportunity for ELTP if selected. It would be the best thing that could happen to ELTP if selected. Nasrat would simply point out we are the only pharm that can make a very safe narcotic in the form of Sequestox. The DEA would be all over the FDA to get Sequestox approved very quickly. We should be so lucky to get selected.

nasdaq2020-Very nice !!!!!!!Ask ELT P if they will put this on their website

N2K-Thanks for being the voice of reason and intellectual common sense around here.

I would add a note of logic. Why would Pfizer and other big pharmas have spent millions and millions of dollars in research to develop over years and years a Sequestox like medication? I am sure they did not do this for pratice. All of big pharma thought this was an important drug to develop. Obviously, big pharma came up short of their goal. Sequestox is the best drug out there. Weezul is correct that any drug is subject to overdosing, even water.

The real gain to be made out of this situation is to accumulate shares. The fact that the 50 day and 200 day are flat and essentially the same is a strong indicator of manipulation at its finest.

Conix- That depends on a lot on your life situation and experience. If you are a novice in the OTC- buy, hold, accumulate is a good strategy. If you have years of experience like yourself on the OTC you can flip all you want. There is no one right answer. The main thing for the novice is not to get frustrated, turn into weak hands, sell, only to find out 6 months from now that the sp is +2.00. Yes, the novice got played.

It means absolutely nothing. Just beating the bushes for more shares.

It is totally absurd to think that after all this time, all this effort, and millions of dollars to get this far, that Nasrat would settle for .97.

The poison pill evaluation of .40-2.70 is significant evidence of outside manipulation of Eltp when the current sp is .10 and this sp does not even take into account of all the progress that has been made. I think Nasrat needs to do another up to date poison pill evaluation especially in light of up coming approvals of ANDAs and Sequestox.This will certainly support a buyout price well above 2.00.

I will see the 1.51 and raise you .50. Nothing less than 2.00.

Imanjen13- If there is a looming trade war with China then the Chinese might speed up the buyout of ELTP even with no Sequestox on the books yet. It could get very interesting very quickly. I am sure Nasrat has a buyout price in mind and if the Chinese meet that price its over Sequestox or no Sequestox.

ElmPa-Nasrat has already given this a lot of thought and planning. Big Pharma is mad at Nasrat. He spent many decades in BigPharma and knows all their tricks and games to pressure OTC companies like ELTP to sellout cheap. Nasrat is too smart to sell out to BigPharma. All BigPharma can do now is buy ELTP shares so soften the blow. First Nasrat got control of ELTP through being paid in shares and also convertible shares which by the way will never see the light of day but converted during the buyout process. So if not BigPharma then who? The first thought is the Chinese , of course. The Chinese do not invest in bad companies nor do dark money funds which have been accumulating shares. Shorting ELTP is a clever way of accumulating shares and making money in both directions. The Chinese like to stay in the background and hidden from view for several reasons. I am thinking the buyout may indirectly occur through Epic. Of course, Epic will not have the financial capability once several ANDAs are approved and Sequestox as well. I think there will be several shell companies and the Chinese will be hidden from sight. This will make it easier to sneak by the SEC and the government. Look what happened to Broadcom and Qualcom. Trump smashed that deal. If you are looking for quick pocket change buy Qualcom as it went down a little. Broadcom is getting a corporate license in Delaware so it can buy Qualcom and Qualcom will bounce back plus a little more before it is all done. Nasrat has a lot of shares so the easiest way for him to retire into the sunset is a buyout. He will be a billionaire. I agree with N2K and you. He wants no interference from the government and a quick deal.

n2k- Nice post. I might add that when Nasrat became CEO his goal was to get control of the majority of outstanding shares. He was paid in shares and has shares he can convert later. He has reached this goal and has sole control of ELTP and can do what he wants which is a buyout for all the reasons you listed. Why get more shares when you now have the controlling interest of shares. I think the fact that Nasrat really does not need anymore shares was behind his recent decision to opt out of getting more shares. He has enough shares now that when ELTP is bought out he will be a billionaire.